Author Question: A nurse would like to facilitate a change within the community. Which of the following actions is ... (Read 30 times)

itsmyluck

  • Hero Member
  • *****
  • Posts: 546
A nurse would like to facilitate a change within the community. Which of the following actions is the nurse likely to take, in view of Lewin's theory of change?
 
  a. Freezing the change by constant persuasion, reinforcement, and use of focus groups
  b. Increasing driving forces, decreasing restraining forces, or doing both
  c. Stabilizing change by decree, rules and procedures, or legislation
  d. Unfreezing the change by using the three techniques described by Lewin

Question 2

People in the community are feeling insecure and vulnerable because the neighborhood is considering closing one of the local elementary schools. Which of the following actions should a nurse take?
 
  a. Ask the formal leader of the group to speak out against the closure.
  b. Ask the informal leader to offer a rationale for the closure.
  c. Offer help and support for those involved.
  d. Offer to write legislators opposing the decision.



morganmarie791

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

ANS: B

Answer to Question 2

ANS: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library